NIHR Imperial Biomedical Research Centre awarded over £1m for research equipment

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre has been awarded more than £1m by the NIHR for equipment that will support vital translational research.

© Chaiyananuwatmongkolchai/Pixabay

© Chaiyananuwatmongkolchai/Pixabay

The equipment will help researchers improve outcomes for patients by increasing access to clinical trials and new treatments across the trust.

A significant portion of the funding will be used to increase capacity in the cellular therapy laboratory, which works with clinicians, scientists and drug companies to deliver new treatments for patients with blood cancers and other blood cell diseases. 

The equipment can help doctors and researchers to enable patients' own cells to destroy their cancer through genetic engineering to replace cells with defects. This could also have significant impact for patients with sickle cell disease and thalassemia, where demand for treatment and research currently exceeds capacity.

Research conducted as part of the NIHR Imperial BRC partnership has previously shown that faecal microbiota transplants can treat gut infections and other gut-related diseases, improving outcomes for patients and reducing infections and time spent in hospital. 

New equipment purchased as part of this grant will be able to deliver the transplant at the Trust in tablet form, rather than through a tube in the stomach, which has been shown to be the preferred method of having the transplant by patients. This will allow further clinical trials to take place, investigating the use of faecal microbiota transplants for other diseases.

BRC neonatal researchers have been testing a new technique, known as a super-resolution ultrasound scan (SRUS), to assess the brains of premature or sick babies at their bedside. This imaging allows doctors to see the tiniest blood vessels and structure of the brain at far greater clarity than MRI. This intervention has the potential to reduce the risk of death or lifelong complications, such as cerebral palsy.

Imperial BRC director, Professor Mark Thursz, said: ‘The new equipment we will acquire as a result of this funding has potential to significantly improve outcomes for patients and will support our research teams to deliver trials with wider access and increased impact more easily.'

Liverpool trust ordered to pay nurse over £200k for failing to implement timely reasonable adjustments

Liverpool trust ordered to pay nurse over £200k for failing to implement timely reasonable adjustments

By Liz Wells 23 April 2025

Mersey Care NHS Foundation Trust has been ordered to pay more than £200,000 to a community nurse after an employment tribunal found it failed to implement ti...

Breakthrough in bowel cancer research to speed up diagnosis

By Liz Wells 23 April 2025

The Government says patients could soon benefit from technology to diagnose bowel cancer earlier, reducing the need for invasive colonoscopies and biopsies, ...

Robotic surgery systems approved for NHS use

By Liz Wells 17 April 2025

NICE has approved 11 robotic surgery systems for use, potentially transforming care for thousands of NHS patients undergoing soft tissue and orthopaedic proc...


Popular articles by Liz Wells